功能遗传学揭示了抗微管体药物敏感性的调节器
Kuan-Chung Su1, Elena Radul1, Nolan K Maier1,2
1Whitehead Institute for Biomedical Research , Cambridge, MA, USA.
The Journal of cell biology
|November 21, 2024
概括
研究人员使用CRISPR屏幕识别了影响细胞对小管体药物 (如诺科达和帕克利塔克塞尔) 敏感性的基因. 这揭示了癌症治疗的新药标和机制.
科学领域:
- 细胞生物学 细胞生物学
- 遗传学 遗传学 是一个
- 药理学 药理学是指药理学的学科.
背景情况:
- 微管对于细胞功能至关重要,是癌症药物的关键标.
- 了解影响药物敏感性的因素对于有效治疗至关重要.
研究的目的:
- 为了识别修改对抗微管药物的敏感性的细胞基因.
- 发现新的治疗点,了解耐药性机制.
主要方法:
- 进行了全基因组的CRISPR/Cas9功能遗传学选.
- 人类细胞被用微管不稳定剂 (诺可达) 和稳定剂 (帕克利塔塞尔) 药物治疗.
- 二次选测试了对细胞系中额外化合物 (STLC) 和基因标的敏感性.
主要成果:
- 鉴定了基因标,增强或抑制对抗微管体剂的敏感性.
- 基于特定化合物和细胞系要求观察到差异性的药物敏感性.
- 发现了已知的微管相关蛋白质的新作用,并确定了新的参与者.
结论:
- 这项研究提供了对抗微管体药物敏感性基因修饰物的全面地图.
- 研究结果提供了对个性化医疗方法和新疗法开发的见解.
更多相关视频
06:02Live Imaging to Study Microtubule Dynamic Instability in Taxane-resistant Breast Cancers
Published on: February 20, 2017
7.5K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.2K
相关概念视频
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Destabilization of Microtubules
2.6K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.6K
Nonlinear Pharmacokinetics: Role of Transporters
33
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
33
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
